InvestorsHub Logo
Followers 7
Posts 444
Boards Moderated 0
Alias Born 01/22/2006

Re: lafont post# 45036

Saturday, 11/28/2009 7:30:43 PM

Saturday, November 28, 2009 7:30:43 PM

Post# of 346043
If the science hits, we have a home run.

lafont, at one time I believed this. But it's simply not my experience. I've posted about this before, so I won't bore you with the details.

I think entdoc may be on to something about patents. An IBM corporate lawyer who's a good friend will not invest in the company (even though he likes the science story) because he thinks that PPHM is a sitting duck. Fighting patent infringements takes a lot of money -- money PPHM doesn't have. Litigation could kill us -- and big pharma would be around to pick up the pieces.

Most disconcerting this past week is the sheer lack of volume. There has been relentless selling pressure all week on low volume. It is not conspiratorial to consider that there's a game afoot -- and the game is fixed. The past several years should have taught us that markets are neither efficient nor free nor just. The market is a Darwinian creature -- survival of the fittest. The fittest of companies are those whose management, first and foremost, can take an idea/product and execute profit from it efficiently. PPHM is in danger of being eaten alive by those higher in the market's evolutionary food chain. No matter how I wish to avoid facing it, time is running out on management's credibility to deliver.

$2.50 is my line in the sand. Below that, and this shareholder of 10 years will need to lick his wounds and find greener pastures.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News